Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Lamblin

Showing results (21-30 of 163) with videos related to

Pageof 17
Sort By:
Open Heart|May 14, 2020
Secondary prevention and outcomes in outpatients with coronary artery disease, atrial fibrillation or heart failure: a focus on disease overlapNicolas Lamblin, Sandro Ninni, Olivier Tricot, et al.
European Journal of Heart Failure|October 15, 2011
Circulating levels of hepatocyte growth factor and left ventricular remodelling after acute myocardial infarction (from the REVE-2 study)Nicolas Lamblin, Anne Bauters, Marie Fertin, et al.
Journal of the American College of Cardiology|May 4, 2004
B-type natriuretic peptide and peak exercise oxygen consumption provide independent information for risk stratification in patients with stable congestive heart failurePascal de Groote, Joël Dagorn, Benoit Soudan, et al.
Thrombosis Journal|September 16, 2003
Angiotensin Converting Enzyme and Angiotensin II Type 1 Receptor Polymorphisms in Patients with Coronary AneurysmsNicolas Lamblin, Xavier Hermant, Jean-Marc Lablanche, et al.
Journal of Cardiac Failure|October 9, 2018
First Hospitalization for Heart Failure in Outpatients With Stable Coronary Artery Disease: Determinants, Role of Incident Myocardial Infarction, and PrognosisNicolas Lamblin, Thibaud Meurice, Olivier Tricot, et al.
ESC Heart Failure|September 12, 2020
Relative impact of bleedings over ischaemic events in patients with heart failure: insights from the CARDIONOR registryGilles Lemesle, Sandro Ninni, Pascal de Groote, et al.
Congestive Heart Failure (Greenwich, Conn.)|August 4, 2007
Prevalence and determinants of cognitive impairment in chronic heart failure patientsStéphanie Debette, Christophe Bauters, Didier Leys, et al.
Journal of the American College of Cardiology|July 10, 2002
Polymorphisms in the promoter regions of MMP-2, MMP-3, MMP-9 and MMP-12 genes as determinants of aneurysmal coronary artery diseaseNicolas Lamblin, Christophe Bauters, Xavier Hermant, et al.
ESC Heart Failure|September 20, 2019
Efficacy of immunosuppressants with bridge vasodilator therapy in severe lupus erythematosus-associated pulmonary arterial hypertensionSébastien Sanges, Laurent Savale, Nicolas Lamblin, et al.
Heart (British Cardiac Society)|June 21, 2014
Prognostic impact of ß-blocker use in patients with stable coronary artery diseaseChristophe Bauters, Gilles Lemesle, Thibaud Meurice, et al.
Pageof 17

Showing results (21-30 of 163) with videos related to

Sort By:
Pageof 17
Open Heart|May 14, 2020
Secondary prevention and outcomes in outpatients with coronary artery disease, atrial fibrillation or heart failure: a focus on disease overlapNicolas Lamblin, Sandro Ninni, Olivier Tricot, et al.
European Journal of Heart Failure|October 15, 2011
Circulating levels of hepatocyte growth factor and left ventricular remodelling after acute myocardial infarction (from the REVE-2 study)Nicolas Lamblin, Anne Bauters, Marie Fertin, et al.
Journal of the American College of Cardiology|May 4, 2004
B-type natriuretic peptide and peak exercise oxygen consumption provide independent information for risk stratification in patients with stable congestive heart failurePascal de Groote, Joël Dagorn, Benoit Soudan, et al.
Thrombosis Journal|September 16, 2003
Angiotensin Converting Enzyme and Angiotensin II Type 1 Receptor Polymorphisms in Patients with Coronary AneurysmsNicolas Lamblin, Xavier Hermant, Jean-Marc Lablanche, et al.
Journal of Cardiac Failure|October 9, 2018
First Hospitalization for Heart Failure in Outpatients With Stable Coronary Artery Disease: Determinants, Role of Incident Myocardial Infarction, and PrognosisNicolas Lamblin, Thibaud Meurice, Olivier Tricot, et al.
ESC Heart Failure|September 12, 2020
Relative impact of bleedings over ischaemic events in patients with heart failure: insights from the CARDIONOR registryGilles Lemesle, Sandro Ninni, Pascal de Groote, et al.
Congestive Heart Failure (Greenwich, Conn.)|August 4, 2007
Prevalence and determinants of cognitive impairment in chronic heart failure patientsStéphanie Debette, Christophe Bauters, Didier Leys, et al.
Journal of the American College of Cardiology|July 10, 2002
Polymorphisms in the promoter regions of MMP-2, MMP-3, MMP-9 and MMP-12 genes as determinants of aneurysmal coronary artery diseaseNicolas Lamblin, Christophe Bauters, Xavier Hermant, et al.
ESC Heart Failure|September 20, 2019
Efficacy of immunosuppressants with bridge vasodilator therapy in severe lupus erythematosus-associated pulmonary arterial hypertensionSébastien Sanges, Laurent Savale, Nicolas Lamblin, et al.
Heart (British Cardiac Society)|June 21, 2014
Prognostic impact of ß-blocker use in patients with stable coronary artery diseaseChristophe Bauters, Gilles Lemesle, Thibaud Meurice, et al.
Pageof 17